BioTech

STAT Plus: At JPM, a debate on Alzheimer’s illness, some household drama in oncology, and a beaten-down biotech

SAN FRANCISCO — Whereas the early hours of biotech’s greatest annual assembly didn’t carry any of the 10-figure transactions that are likely to please buyers, the J.P. Morgan Healthcare Convention supplied lots to debate in relation to the way forward for drugs.

Listed here are among the highlights thus far, together with a hot-button situation in Alzheimer’s illness, some household drama in oncology, and a reliably upbeat CEO compelled to reckon with undeniably unhealthy information.

Proceed to STAT Plus to learn the complete story…

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker